Loading…
Rockwell Medical Inc
How the company evolved, year by year. Revenue and debt come from the annual reports — for most companies, the 10-K filings with the SEC since 2009; dividends from the payments themselves.
The bars are a balance on the closing date; the lines are what happened during the year. Revenue above equity is ordinary, not an anomaly — it means the company turns its capital over more than once a year.
Major managers that reported this stock in their latest 13F.
None of the investors we track reported a position in RMTI.
▼ -85.9% over 5Y.
today you would have $126.82▼ -87.3%
Dividends reinvested, splits accounted for. Past prices say what happened, not what will.
The last 17 closed years. Each multiple uses that year’s closing price and that year’s reported numbers — not today’s. The range is set by the annual reports on record.
| Indicator | Median | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Year-end price | $8.30 | $20.40 | $18.90 | $10.10 | $45.10 | $111.10 | $268.40 | $248.60 | $640.20 | $720.50 | $1,126.40 | $1,130.80 | $1,148.40 | $885.50 | $931.70 | $869.00 | $845.90 |
Companies of similar size in Healthcare, for comparison. The columns are the same ones above, in the same order.
| Stock | Price | P/E | P/B | Dividend yield | ROE | Market cap |
|---|---|---|---|---|---|---|
| KYNBKyntra Bio Inc | $8.02 | — | — | — | — | $32.47M |
| BCTXBriaCell Therapeutics Corp. | $3.73 | — | 1.1x | — | -175.25% | $32.45M |
| PETSPetmed Express Inc | $1.55 | — | 1.4x | — | -78.56% | $33.6M |
| CCELCryo Cell International Inc | $4.00 |
Rockwell Medical, Inc., together with its subsidiaries, engages in the development, manufacture, commercialization, and distribution of various hemodialysis products for dialysis providers worldwide. It offers citrapure citric acid concentrate, dri-sate dry acid concentrate, renalpure liquid acid concentrate, dri-sate acid concentrate mixer, renalpure acid concentrate, renalpure bicarbonate concentrate, sterilyte bicarbonate concentrate, bicarbonate cartridges, and dry acid concentrate mixer, as well as ancillary products, including 5% acetic acid, cleaner, citric acid descaler, water softener salt pellets, and other supplies used by hemodialysis providers. The company's hemodialysis concentrate products are used to sustain patient's life by removing toxins and balancing electrolytes in a dialysis patient's bloodstream. In addition, it offers dialysis concentrates, dialysis kits, and other ancillary products used in the dialysis process. The company was formerly known as Rockwell Medical Technologies, Inc. and changed its name to Rockwell Medical, Inc. in June 2012. Rockwell Medical, Inc. was incorporated in 1996 and is headquartered in Wixom, Michigan.
Company description provided by Yahoo Finance.
| P/S | 2.5x | 0.5x | 0.7x | 0.7x | 0.2x | 0.6x | 1.5x | 2.7x | 2.0x | 5.3x | 6.3x | 9.5x | 9.6x | 8.1x | 3.5x | 3.6x | 2.3x | — |
| P/B | 6.4x | 0.9x | 2.1x | 2.6x | 0.9x | 15.2x | 2.8x | 8.3x | 4.7x | 9.2x | 6.4x | 8.5x | 7.5x | 714.3x | — | 9.6x | 4.5x | — |
| EPS | -$1.50 | -$0.30 | -$3.70 | -$13.10 | -$38.30 | -$45.10 | -$61.60 | -$67.10 | -$56.10 | -$42.90 | -$31.90 | -$57.20 | -$162.80 | -$291.50 | -$133.10 | -$17.60 | -$40.70 |
| Profit margin | -39.36% | -7.67% | -0.47% | -10.09% | -25.65% | -52.76% | -49.66% | -55.67% | -50.68% | -45.24% | -37.16% | -26.05% | -39.36% | -93.13% | -108.38% | -43.79% | -4.51% | -10.05% |
| ROE | -59.20% | -14.37% | -1.47% | -39.64% | -132.42% | -1288.92% | -90.40% | -167.95% | -117.78% | -78.76% | -37.39% | -23.14% | -31.04% | -8191.46% | — | -117.54% | -8.79% | -18.76% |
Median, not average: a single year of near-zero profit produces a P/E of 400 and would drag an average on its own. P/E years above 200x are left out, the same cut the fair price uses — so this median matches the “its own history” method below. Price and EPS have no median: they are series that grow.
| — |
| — |
| 15.00% |
| — |
| $32.25M |
| NSYSNortech Systems Inc | $11.84 | 33.8x | 1.0x | — | 3.00% | $33.79M |
| IGCIGC Pharma, Inc. | $0.31 | — | 5.2x | — | -83.34% | $32.05M |